Value of N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-c TnT) as markers of left ventricular hypertrophy in the potentially healthy populations

11 April 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Associate Professor Malgorzata Chlabicz

Medical University of Bialystok, Bialystok (Poland)

45 More presentations in this session

Presentation thumbnail

Sensitivity and specificity of cardiovascular risk thresholds used to guide treatment therapy

Professor A. Oulhaj (Abu Dhabi, AE)

Presentation thumbnail

Assessment of the additional capacity of a genetic risk score in the prediction of coronary artery disease and its discriminative power

Doctor J. Sousa (Funchal, PT)

Abstract Slides

Presentation thumbnail

Impact of a cardiovascular disease screening result on prevention-seeking behavior and compliance with preventive treatment in asymptomatic ROBINSCA participants

Ms S. Denissen (Rotterdam, NL)

Presentation thumbnail

Aseptic loosening after total hip arthroplasty and the risk of cardiovascular disease; a nested control study

Presentation thumbnail

Subclinical abnormalities in left atrial - left ventriculoarterial coupling in middle - aged hypertensive patients

Doctor N. Georgieva (Sofia, BG)

Access the full session

Session thumbnail

Poster Session 2 - Risk Factors and Prevention – Cardiovascular Risk Assessment

The Event

EuroPrevent 2019

11 April - 13 April 2019

You may be interested in

Congress Presentation

Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers

Webinar

Biomarkers of clinical utility in cardiovascular disease

Congress Presentation

Implementing cardiac biomarkers in clinical practice: insights from risk stratification with high-sensitivity troponin in asymptomatic individuals

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources